KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Castle Biosciences (CSTL) Long-Term Debt Issuances (2018 - 2024)

Castle Biosciences (CSTL) has disclosed Long-Term Debt Issuances for 2 consecutive years, with $10.0 million as the latest value for Q1 2024.

  • Quarterly Long-Term Debt Issuances changed N/A to $10.0 million in Q1 2024 from the year-ago period, while the trailing twelve-month figure was $10.0 million through Dec 2024, changed N/A year-over-year, with the annual reading at $10.0 million for FY2024, N/A changed from the prior year.
  • Long-Term Debt Issuances hit $10.0 million in Q1 2024 for Castle Biosciences, up from $1.0 million in the prior quarter.
  • In the past five years, Long-Term Debt Issuances ranged from a high of $10.0 million in Q1 2024 to a low of $10.0 million in Q1 2024.